Vulvar Squamous Cell Carcinoma (VSCC) patients research hub

COLOMBE - A multicentre, single arm, phase 1/2 study, aiming to assess the safety and efficacy of nivolumab and imiquimod combination in vulvar squamous cell carcinoma patients

This study is looking at a new combination treatment for vulvar squamous cell carcinoma. It aims to see how safe and effective a cream (imiquimod) given with an intravenous drug (nivolumab) is in helping women with this type of cancer.